Brief: Somnomed Says FY24 EBITDA Guidance Revised To Between A$0.3 Mln & A$0.8 Mln

SomnoMed

24/07/2024 01:19

July 24 (Reuters) - Somnomed Ltd  SOM.AX :
    * FY24 EBITDA GUIDANCE REVISED UPWARDS TO BETWEEN A$0.3
MILLION TO
A$0.8 MILLION

Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))